321
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Plasma Sex-Related Hormones Levels with Bone Mineral Densities and Risk of Osteoporosis and Osteopenia in Men and Menopausal Women with Type 2 Diabetes Mellitus

, , , ORCID Icon, & ORCID Icon
Pages 457-468 | Received 20 Dec 2022, Accepted 02 Feb 2023, Published online: 14 Feb 2023

References

  • Sellmeyer DE, Civitelli R, Hofbauer LC, Khosla S, Lecka-Czernik B, Schwartz AV. Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes. Diabetes. 2016;65(7):1757–1766. doi:10.2337/db16-0063
  • Costantini S, Conte C. Bone health in diabetes and prediabetes. World J Diabetes. 2019;10(8):421–445.
  • Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2007;18(4):427–444.
  • Wang J, You W, Jing Z, Wang R, Fu Z, Wang Y. Increased risk of vertebral fracture in patients with diabetes: a meta-analysis of cohort studies. Int Orthop. 2016;40(6):1299–1307.
  • Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455–468.
  • De L, Van Der Klift M, De Laet CE, Van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int. 2005;16(12):1713–1720.
  • Lipscombe LL, Jamal SA, Booth GL, Hawker GA. The risk of Hip fractures in older individuals with diabetes: a population-based study. Diabetes Care. 2007;30(4):835–841.
  • Nguyen HT, Von Schoultz B, Nguyen TV, et al. Sex hormone levels as determinants of bone mineral density and osteoporosis in Vietnamese women and men. J Bone Miner Metab. 2015;33(6):658–665.
  • Deng X, Wang W, Wu X, et al. Correlation between bone mineral density and sexual hormones in healthy Chinese women. J Environ Pathol Toxicol Oncol. 2000;19(1–2):167–169.
  • Mellstrom D, Johnell O, Ljunggren O, et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: mrOS Sweden. J Bone Miner Res. 2006;21(4):529–535.
  • Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331(16):1056–1061.
  • Woo J, Kwok T, Leung JC, Ohlsson C, Vandenput L, Leung PC. Sex steroids and bone health in older Chinese men. Osteoporos Int. 2012;23(5):1553–1562.
  • Egund L, Isaksson S, Mcguigan FE, Giwercman A, Akesson KE. High luteinizing hormone and lower levels of sex hormones in younger men with distal radius fracture. JBMR Plus. 2020;4(11):e10421.
  • Vandenput L, Lorentzon M, Sundh D, et al. Serum estradiol levels are inversely associated with cortical porosity in older men. J Clin Endocrinol Metab. 2014;99(7):E1322–E1326.
  • Jing Y, Wang X, Yu J, et al. Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus. J Diabetes. 2020;12(6):426–437.
  • Cauley JA. Estrogen and bone health in men and women. Steroids. 2015;99(Pt A):11–15.
  • Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L; MRFIT Research Group. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;143(9):889–897.
  • Xia JW, Tan SJ, Zhang XL, Jun T, Sun XK, Ling W. Correlation of serum testosterone with insulin resistance in elderly male type 2 diabetes mellitus patients with osteoporosis. J Diabetes Investig. 2015;6(5):548–552.
  • Zheng S, Zhou J, Wang K, Wang X, Li Z, Chen N. Associations of obesity indices with bone mineral densities and risk of osteoporosis stratified across diabetic vascular disease in T2DM patients. Diabetes Metab Syndr Obes. 2022;15:3459–3468.
  • Jellinger PS, Handelsman Y, Rosenblit PD, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23(Suppl 2):1–87.
  • Jiang X, Gruner M, Tremollieres F, et al. Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: a systematic review and meta-analysis. Bone. 2017;99:20–25.
  • Ohnaka K. Aging and homeostasis sex hormones and aging. Clin Calcium. 2017;27(7):947–954.
  • Bhattarai HK, Shrestha S, Rokka K, Shakya R. Vitamin D, calcium, parathyroid hormone, and sex steroids in bone health and effects of aging. J Osteoporos. 2020;2020:9324505.
  • Gambacciani M, Levancini M. Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny. 2014;13(4):213–220.
  • De Villiers TJ, Stevenson JC, The WHI. the effect of hormone replacement therapy on fracture prevention. Climacteric. 2012;15(3):263–266.
  • Weber TJ. Battle of the sex steroids in the male skeleton: and the winner is. J Clin Invest. 2016;126(3):829–832.
  • Cawthon PM, Schousboe JT, Harrison SL, et al.; Osteoporotic Fractures in Men Study Research G. Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. Bone. 2016;84:271–278.
  • Orwoll ES, Lapidus J, Wang PY, et al.; Osteoporotic Fractures in Men Study Research G. The limited clinical utility of testosterone, estradiol, and sex hormone binding globulin measurements in the prediction of fracture risk and bone loss in older men. J Bone Miner Res. 2017;32(3):633–640.
  • Moran JM, Lavado-Garcia JM, Roncero-Martin R, et al. Testosterone levels and bone mineral density in healthy elderly men. J Am Geriatr Soc. 2015;63(1):206–207.
  • Yeap BB, Alfonso H, Center JR, et al. U-shaped association of plasma testosterone, and no association of plasma estradiol, with incidence of fractures in men. J Clin Endocrinol Metab. 2020;105:5.
  • Shigehara K, Konaka H, Koh E, et al. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). Aging Male. 2017;20(3):139–145.
  • Tryniszewski W, Kaminski G, Maziarz Z, Nowak M, Gadzicki M, Radek M. The assessment of testosterone and radioisotopic index of bone metabolism and bone mineral density in men with testosterone deficiency after one year of testosterone therapy. Nucl Med Rev Cent East Eur. 2018;21(1):14–19.
  • Junjie W, Dongsheng H, Lei S, Hongzhuo L, Changying S. Testosterone replacement therapy has limited effect on increasing bone mass density in older men: a meta-analysis. Curr Pharm Des. 2019;25(1):73–84.
  • Tok EC, Ertunc D, Oz U, Camdeviren H, Ozdemir G, Dilek S. The effect of circulating androgens on bone mineral density in postmenopausal women. Maturitas. 2004;48(3):235–242.
  • Sowers MR, Finkelstein JS, Ettinger B, et al.; Study of Women’s Health across The N. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int. 2003;14(1):44–52.
  • Sowers MR, Jannausch M, Mcconnell D, et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab. 2006;91(4):1261–1267.
  • Xu ZR, Wang AH, Wu XP, et al. Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin Chim Acta. 2009;400(1–2):8–13.
  • Gioia A, Ceccoli L, Ronconi V, et al. Vitamin D levels and bone mineral density: are LH levels involved in the pathogenesis of bone impairment in hypogonadal men? J Endocrinol Invest. 2014;37(12):1225–1231.
  • Seriwatanachai D, Krishnamra N, Van Leeuwen JP. Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization. J Cell Biochem. 2009;107(4):677–685.
  • Seriwatanachai D, Thongchote K, Charoenphandhu N, et al. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio. Bone. 2008;42(3):535–546.
  • Sealand R, Razavi C, Adler RA. Diabetes mellitus and osteoporosis. Curr Diab Rep. 2013;13(3):411–418.
  • Viegas M, Costa C, Lopes A, Griz L, Medeiro MA, Bandeira F. Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications. J Diabetes Complications. 2011;25(4):216–221.
  • Key TJ, Appleby PN, Reeves GK, et al.; Endogenous Hormones Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95(16):1218–1226.
  • Mills EG, Yang L, Nielsen MF, Kassem M, Dhillo WS, Comninos AN. The relationship between bone and reproductive hormones beyond estrogens and androgens. Endocr Rev. 2021;42(6):691–719.
  • Eastell R, O’Neill TW, Hofbauer LC, et al. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2:16069.
  • Khosla S. New insights into androgen and estrogen receptor regulation of the male skeleton. J Bone Miner Res. 2015;30(7):1134–1137.